These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 38481570)

  • 21. Regulation of Synthetic Biology: Developments Under the Convention on Biological Diversity and Its Protocols.
    Keiper F; Atanassova A
    Front Bioeng Biotechnol; 2020; 8():310. PubMed ID: 32328486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial Intelligence: Guidance for clinical imaging and therapeutic radiography professionals, a summary by the Society of Radiographers AI working group.
    Malamateniou C; McFadden S; McQuinlan Y; England A; Woznitza N; Goldsworthy S; Currie C; Skelton E; Chu KY; Alware N; Matthews P; Hawkesford R; Tucker R; Town W; Matthew J; Kalinka C; O'Regan T
    Radiography (Lond); 2021 Nov; 27(4):1192-1202. PubMed ID: 34420888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial intelligence technologies and compassion in healthcare: A systematic scoping review.
    Morrow E; Zidaru T; Ross F; Mason C; Patel KD; Ream M; Stockley R
    Front Psychol; 2022; 13():971044. PubMed ID: 36733854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic Biology in the FDA Realm: Toward Productive Oversight Assessment.
    Fatehi L; Hall RF
    Food Drug Law J; 2015; 70(2):339-69, iii-iv. PubMed ID: 26302603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AI governance in the public sector: Three tales from the frontiers of automated decision-making in democratic settings.
    Kuziemski M; Misuraca G
    Telecomm Policy; 2020 Jul; 44(6):101976. PubMed ID: 32313360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Legal concerns in health-related artificial intelligence: a scoping review protocol.
    Da Silva M; Horsley T; Singh D; Da Silva E; Ly V; Thomas B; Daniel RC; Chagal-Feferkorn KA; Iantomasi S; White K; Kent A; Flood CM
    Syst Rev; 2022 Jun; 11(1):123. PubMed ID: 35715812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current challenges of implementing artificial intelligence in medical imaging.
    Saw SN; Ng KH
    Phys Med; 2022 Aug; 100():12-17. PubMed ID: 35714523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial intelligence challenges in the face of biological threats: emerging catastrophic risks for public health.
    de Lima RC; Sinclair L; Megger R; Maciel MAG; Vasconcelos PFDC; Quaresma JAS
    Front Artif Intell; 2024; 7():1382356. PubMed ID: 38800763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From CBA to Precautionary Appraisal: Practical Responses to Intractable Problems.
    Stirling A; Coburn J
    Hastings Cent Rep; 2018 Jan; 48 Suppl 1():S78-S87. PubMed ID: 29453838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generative Artificial Intelligence Terminology: A Primer for Clinicians and Medical Researchers.
    Melnyk O; Ismail A; Ghorashi NS; Heekin M; Javan R
    Cureus; 2023 Dec; 15(12):e49890. PubMed ID: 38174178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation and management of the biosecurity for synthetic biology.
    Zeng X; Jiang H; Yang G; Ou Y; Lu S; Jiang J; Lei R; Su L
    Synth Syst Biotechnol; 2022 Jun; 7(2):784-790. PubMed ID: 35387231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Generative Conversational Artificial Intelligence on the Lesbian, Gay, Bisexual, Transgender, and Queer Community: Scoping Review.
    Bragazzi NL; Crapanzano A; Converti M; Zerbetto R; Khamisy-Farah R
    J Med Internet Res; 2023 Dec; 25():e52091. PubMed ID: 37864350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework.
    Destura RV; Lam HY; Navarro RC; Lopez JCF; Sales RKP; Gomez MIFA; Dela Tonga A; Ulanday GE
    Appl Biosaf; 2021 Dec; 26(4):232-244. PubMed ID: 36034094
    [No Abstract]   [Full Text] [Related]  

  • 34. Multi-scale governance and data for sustainable development.
    Pastor-Escuredo D; Gardeazabal A; Koo J; Imai A; Treleaven P
    Front Big Data; 2022; 5():1025256. PubMed ID: 36532845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Governing AI during a pandemic crisis: Initiatives at the EU level.
    Fontes C; Corrigan C; Lütge C
    Technol Soc; 2023 Feb; 72():102204. PubMed ID: 36777094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombination between coronaviruses and synthetic RNAs and biorisk implications motivated by a SARS-CoV-2 FCS origin controversy.
    Mueller S
    Front Bioeng Biotechnol; 2023; 11():1209054. PubMed ID: 37600318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biorisk Management for Clinical Diagnostic Laboratories].
    Shigematsu M
    Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore.
    Trump BD
    Health Policy; 2017 Nov; 121(11):1139-1146. PubMed ID: 28807332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shaping the science-industry-policy interface in synthetic biology.
    Gaisser S; Reiss T
    Syst Synth Biol; 2009 Dec; 3(1-4):109-14. PubMed ID: 19816806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Use Quickscan: A Web-Based Tool to Assess the Dual-Use Potential of Life Science Research.
    Vennis IM; Schaap MM; Hogervorst PAM; de Bruin A; Schulpen S; Boot MA; van Passel MWJ; Rutjes SA; Bleijs DA
    Front Bioeng Biotechnol; 2021; 9():797076. PubMed ID: 34957083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.